MedTrace Logo

Cell Surface Marker Expression in Autoimmune Diseases

NCT03757065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2020-08-27

No results posted yet for this study

Summary

This study is designed to explore the expression of cell-surface markers in the following seven disease areas: (a) systemic lupus erythematosus, (b) Sjogren's syndrome, (c) multiple sclerosis, (d) systemic sclerosis, (e) Crohn's disease, (f) ulcerative colitis and (g) inflammatory myositis.

Conditions

Sponsors & Collaborators

  • Alpine Immune Sciences, Inc.

    lead INDUSTRY

Principal Investigators

  • Jan Hillson, MD · Alpine Immune Sciences

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2019-10-25
Completion
2019-10-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03757065 on ClinicalTrials.gov